LivingGLP1
Study S002688

INFLUENCE OF GUT MICROBIOTA ON THE DEVELOPMENT OF TYPE 2 DIABETES MELLITUS AND PERSONALIZATION OF DIABETES-LOWING THERAPY

ClinicalTrials.gov record

Registration

Registration
NCT07627048
Acronym
GM
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
100
Start
2021-12-01
Primary completion
2021-12-01
Lead sponsor
Pirogov Russian National Research Medical University
Conditions
Type 2 Diabetes (T2DM)
Results posted
FALSE

Registered primary outcomes

  • Number of participants with domination of different bacterial species in the stool analysis [3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.